A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Data based on numbers of 27th of Apr '20 | WORLD AVERAGE 26.7 DEATHS PER MILLION | |||||||||||||||||||||||
2 | In order of COVID DEATHS PER MILLION | ||||||||||||||||||||||||
3 | Author: @NarqieTweets | Sources: | https://www.worldometers.info/coronavirus/#countries | ||||||||||||||||||||||
4 | https://www.who.int/malaria/travellers/en/ | ||||||||||||||||||||||||
5 | https://en.wikipedia.org/wiki/List_of_countries_by_average_yearly_temperature | ||||||||||||||||||||||||
6 | https://www.cdc.gov/malaria/travelers/country_table/a.html | ||||||||||||||||||||||||
7 | https://www.fitfortravel.nhs.uk/destinations | ||||||||||||||||||||||||
8 | |||||||||||||||||||||||||
9 | COUNTRY, Other | COVID DEATHS/MILLION | AVERAGE YEARLY TEMP (C) | MALARIA PREVENTION ADVICE BY WHO | MALARIA RISK | ||||||||||||||||||||
10 | San Marino | 1208 | 11.85 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
11 | Belgium | 622 | 9.55 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
12 | Andorra | 518 | 7.60 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
13 | Spain | 503 | 13.30 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
14 | Italy | 441 | 13.45 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
15 | France | 350 | 10.70 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
16 | United Kingdom | 305 | 8.45 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
17 | Netherlands | 264 | 9.25 | None | Not normally present unless the illness was contracted abroad | COVID WORLD MAP | |||||||||||||||||||
18 | Sweden | 225 | 2.10 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
19 | Ireland | 220 | 9.30 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
20 | Isle of Man | 212 | 6.50 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
21 | Channel Islands | 201 | 13.00 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
22 | Montserrat | 200 | 16.80 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
23 | Switzerland | 189 | 5.50 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
24 | United States of America | 167 | 8.55 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
25 | Luxembourg | 141 | 8.65 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
26 | Monaco | 102 | 13.55 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
27 | Bermuda | 96 | 25.00 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
28 | Portugal | 89 | 15.15 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
29 | Denmark | 73 | 7.50 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
30 | Germany | 71 | 8.50 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
31 | Iran | 69 | 17.25 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | Low to no risk | ||||||||||||||||||||
32 | Canada | 68 | -5.35 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
33 | Austria | 61 | 6.35 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
34 | Slovenia | 40 | 8.90 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
35 | Panama | 38 | 25.40 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | Low to no risk | ||||||||||||||||||||
36 | Estonia | 38 | 5.10 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
37 | Norway | 37 | 1.50 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
38 | Martinique | 37 | 26.20 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
39 | Finland | 34 | 1.70 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
40 | Turkey | 33 | 11.10 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
41 | Ecuador | 33 | 21.85 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | Low to no risk | ||||||||||||||||||||
42 | Romania | 33 | 8.80 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
43 | British Virgin Islands | 33 | 27.00 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
44 | Antigua and Barbuda | 31 | 26.00 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
45 | Guadeloupe | 30 | 30.00 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
46 | Hungary | 29 | 9.75 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
47 | Iceland | 29 | 1.75 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
48 | North Macedonia | 29 | 9.80 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
49 | Bahamas | 28 | 24.85 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
50 | Dominican Republic | 26 | 24.55 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | Low to no risk | ||||||||||||||||||||
51 | Liechtenstein | 26 | 12.50 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
52 | Turks and Caicos | 26 | 25.75 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
53 | Moldova | 25 | 9.45 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
54 | Israel | 23 | 19.20 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
55 | Peru | 22 | 19.60 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | N/E high - rest low to no risk | ||||||||||||||||||||
56 | Czechia | 21 | 7.55 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
57 | Barbados | 21 | 26.00 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
58 | Brazil | 20 | 24.95 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | N/W high - rest low risk | ||||||||||||||||||||
59 | Aruba | 19 | 28.50 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
60 | Serbia | 18 | 10.55 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
61 | Bosnia and Herzegovina | 18 | 9.85 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
62 | Lithuania | 15 | 6.20 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
63 | Mayotte | 15 | 25.50 | Mosquito avoidance only | Low to no risk | ||||||||||||||||||||
64 | Cayman Islands | 15 | 27.25 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
65 | Poland | 14 | 7.85 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
66 | Croatia | 14 | 10.90 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
67 | Greece | 13 | 15.40 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
68 | Cyprus | 12 | 18.45 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
69 | Montenegro | 11 | 10.55 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
70 | Mexico | 10 | 21.00 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | Low to no risk | ||||||||||||||||||||
71 | Chile | 10 | 8.45 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
72 | Algeria | 10 | 22.50 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
73 | Armenia | 10 | 7.15 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
74 | Albania | 10 | 11.40 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
75 | Guyana | 10 | 26.00 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | High risk | ||||||||||||||||||||
76 | Malta | 9 | 19.20 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
77 | Belarus | 8 | 6.15 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
78 | United Arab Emirates | 8 | 27.00 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
79 | Bulgaria | 8 | 10.55 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
80 | Latvia | 7 | 5.60 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
81 | Mauritius | 7 | 22.40 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
82 | Honduras | 6 | 23.50 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | W low to no risk - Middle low - E high risk | ||||||||||||||||||||
83 | Trinidad and Tobago | 6 | 25.75 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
84 | Curacao | 6 | 27.50 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
85 | Russia | 5 | -5.10 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
86 | South Korea | 5 | 11.50 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | Low to no risk | ||||||||||||||||||||
87 | Ukraine | 5 | 8.30 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
88 | Philippines | 5 | 25.85 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | Low to no risk | ||||||||||||||||||||
89 | Colombia | 5 | 24.50 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | E & W high - Middle low to no risk | ||||||||||||||||||||
90 | Bahrain | 5 | 27.15 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
91 | Cuba | 5 | 25.20 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
92 | Belize | 5 | 25.30 | Mosquito avoidance only | Low to no risk | ||||||||||||||||||||
93 | Saudi Arabia | 4 | 24.65 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | Low to no risk | ||||||||||||||||||||
94 | Morocco | 4 | 17.10 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
95 | Argentina | 4 | 14.80 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
96 | New Zealand | 4 | 10.55 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
97 | Bolivia | 4 | 21.55 | Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine | N high risk - Rest low to no risk | ||||||||||||||||||||
98 | Lebanon | 4 | 16.40 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
99 | Uruguay | 4 | 17.55 | None | Not normally present unless the illness was contracted abroad | ||||||||||||||||||||
100 | China | 3 | 6.95 | Mosquito avoidance only | Low to no risk |